An association between ADA 1 and Coronary Artery Disease (CAD) has been observed in Polish and in Italian populations but in Italian population the association was present in males only. In order to enlighten these differences we have carried out a collaborative study in the two populations. In Italy 215 subjects admitted to the Hospital for CAD, 275 subjects with Type 2 Diabetes (T2D) without CAD and 398 healthy newborns were studied. In Poland 173 subjects with CAD and 200 healthy newborns were studied. Written informed consent was obtained from all subjects or from their mothers to participate to the study that was approved by the I.R.B. ADA 1 polymorphism was determined by DNA analysis. Three way contingency table analysis was performed by a log linear model. The association between CAD and ADA 1 is present in non diabetic male subjects only: OR = 0.195, p = 0.007 in the Italian population and OR = 0.163, p = 0.004 in the Polish population. The data suggest a significant role of immunological mechanisms in the pathogenesis of CAD without diabetes. Gender differences in immune diseases could explain the lack of association in females.
INTRODUCTION
An association between Adenosine Deaminase locus 1 (ADA 1 ) and Coronary Artery Disease (CAD) has been described in the Polish population [1] and confirmed in the Italian population [2] . In Italy, however, a significant association was found in males only. In order to enlighten these differences we have carried out a collaborative study involving both populations.
ADA 1 is a polymorphic enzyme present in all mammalian tissue that catalyzes the irreversible deamination of adenosine to inosine [3] . It is controlled by a locus with 2 codominant alleles ADA 1 *1 and ADA 1 *2 located in the long arm of chromosome 20 [4] : the activity associated to ADA 1 *2 is lower than that associated to ADA 1 *1.
Adenosine is an important local hormone regulating blood flow, neurotransmission, physiology of smooth muscle and platelet aggregation. In the liver adenosine counteracts insulin action by activating A2B receptors [5] . ADA 1 and CD26 are colocalized on T cell surface and these cells are much more resistant to the inhibitory effects of adenosine.
Adenosine is a cardioprotective agent [6] , thus reduced activity in ADA 1 *2 allele carriers may have a beneficial effect on cardiac function. Moreover ecto-ADA 1 interacts with Adenosine receptor A 1 [7] which plays an important role in ischaemic preconditioning [8] . Inhibition of platelet aggregation and adhesion and antiinflammatory properties of adenosine [9] may also play an important role in the susceptibility to CAD [10] . controls for CAD with T2D).
398 consecutive healthy newborns (as controls for CAD without diabetes). POLAND 173 subjects admitted to the hospital for CAD. 200 consecutive healthy newborns (as controls for CAD without diabetes).
Subjects with type 2 diabetes without CAD were not available for this population.
Written informed consent was obtained from all subjects or from their mothers to participate to the study that was approved by the I.R.B.
Adenosine deaminase genotype determination was carried out as previously described [1] . Three way contingency table analysis was carried out by a log linear model according to Sokal and Rohlf [11] . Table 1 shows the distribution of ADA 1 genotypes (phenotypes) in Coronary Artery Disease (Italy and Poland), in type 2 diabetes without CAD (Italy) and in healthy newborns (Italy and Poland) in relation to gender and Diabetes. The relationship among the variables considered i.e. ADA 1 genotype, CAD, diabetes, gender and population have been examined by log linear models.
RESULTS
The analysis of interaction among ADA 1 , diabetes and gender (a) within CAD subjects shows a significant interaction among the three variables with a pattern similar in Italian and Polish samples. The analysis suggests that the relationship between ADA 1 and diabetes depends on gender.
The analysis of interaction among ADA 1 , CAD (CAD Table 1 . The effect of diabetes and gender on the association between ADA 1 and CAD. vs newborns) and population (b) in non diabetic subjects shows a lack of interaction in both males and females suggesting that the relationship between ADA 1 and CAD is similar in the two populations studied. The association between ADA 1 and CAD is very strong in males (χ 2 = 20.651, df = 2, p 0.0001, after correction for multiple comparison p < 0.001) but is lacking in females.

Since in the Polish population we had no data on diabetic subjects without CAD a similar analysis comparing CAD diabetics with non-CAD diabetics could not be performed.
The analysis of interaction among ADA 1 , gender and population in CAD diabetics (c) shows no significant association between ADA 1 and gender in both Italian and Polish populations. On the contrary the same analysis in CAD non diabetics (d) shows a significant association between ADA 1 and gender that shares a similar pattern in Italian and Polish populations.
From these analyses it can be safely concluded 1) that the association between CAD and ADA 1 is present in non diabetic subjects only and 2) that the pattern of association in non diabetic CAD subjects depends on gender and it is present and very strong among males only: OR (ADA 1 
DISCUSSION
Since a number of newborns will suffer CAD later in their life, it could be objected that these infants do not represent a reliable control for our study. However, assuming that a given genotype is more susceptible with respect to other genotypes to CAD, the difference between cases and newborns would be lower as compared to the difference between cases and adults without CAD. Therefore taking newborns as controls the association of CAD with a given genotype will be underevaluated. If the association is statistically significant "newborns" can be considered a reliable control.
The present data collected in two independent White European populations show that the association between CAD and ADA 1 is present in non diabetic patients only: moreover such association is present and very marked among males only. Considering both populations in males the proportion of genotypes carrying the ADA 1 *2 allele is much lower among CAD patients than among controls.
The difference between males and females could be due to different early fatality rate; such difference, however, is present in non diabetic but not in diabetic subjects and this seems against such hypothesis. Unfortunately, we have no data on the subjects died during the early stages of cardiac attack.
The fact that association between CAD and ADA 1 is present in non diabetic subjects only suggests the existence of different mechanisms leading to CAD. A role of immunological factors has been suggested for atherosclerosis: taking into account the well known role of ADA 1 in immunological diseases, the association of CAD with ADA 1 suggests a prevalent role of immunological factors in the pathogenesis of coronary artery atherosclerosis in CAD without diabetes. In CAD with diabetes a role of metabolic factors could be more important explaining the lack of association with ADA 1 polymorphism.
Gender differences in immune diseases are well documented and it has been suggested that in association studies concerning immune diseases males and females should be examined separately [12] . Thus, assuming an immune component in the association between ADA 1 and CAD the differences observed between males and females are in line with other studies. Hormonal factors may explain these differences. The immune mechanism, however, does not exclude a direct role of adenosine as a cardioprotective agent.
